SKA1 and breast carcinoma: Notably, dysregulated expression of SKA1/2/3 was involved in the tumorigenesis and progression of multiple cancer types such as liver cancer, breast cancer, cervical cancer and other malignant tumors (5–7), which in turn can affect the prognosis of cancer patients.